The Resource for your Nonhuman Primate Research

We offer primate antibodies and recombinant proteins for pre-clinical NHP studies, NHP-specific reagents for in vitro assays, and have an industry wide antibody reactivity database for NHP species.

Recent Publications Using Our Reagents...


Have you tried measuring anti-drug antibodies using our reagents?

Check our Anti-rhesus IgG1/3 [1B3] clone (reacts with monkey but not human IgGs!)

2022 June 26

Protocol for evaluating CD8+ T cell-mediated immunity in latently SHIV-infected rhesus macaques with HIV fusion-inhibitory lipopeptide monotherapy

Yuting Sun, Jingjing Zhang, Ling Tong, Jiahan Lu, Ting Chen, Qiang Wei, Yuxian He, Zh eCong, Jing Xue

STAR Protocols

Anti-CD8 beta [CD8b255R1] Anti-CD8 alpha [MT807R1]

2022 June 07

Preclinical Immunogenicity and Efficacy of a Multiple Antigen-Presenting System (Maps) Sars Cov-2 Vaccin

Cieslewicz Brian , Daniel Makrinos , Heidi Burke , Dara Bree , Renuka Haridas , Ian Tonkiss , Yannic Bartsch , Galit Alter , Richard Malley , Gilles Besin


Anti-rhesus IgG1/3 [1B3]-HRP

2022 May 30

Long-term hepatitis B virus infection of rhesus macaques requires suppression of host immunity.

Biswas, Sreya Rust, Lauren N Wettengel, Jochen M Yusova, Sofiya Fischer, Miranda Carson, Julien N Johnson, Josie Wei, Lei Thode, Trason Kaadige, Mohan R Sharma, Sunil Agbaria, Majd Bimber, Benjamin N Tu, Thomas Protzer, Ulrike Ploss, Alexander Smedley, Jeremy V Golomb, Gershon Sacha, Jonah B Burwitz, Benjamin J

Nat Commun

Anti-CD8 alpha [MT807R1]

News & Updates:

2022 Jan 13

RhATG Discontinuation

We will discontinue the production of rhATG in 2022. Please find the reasons behind this decision on the attached letter (PDF).

2021 Apr 02

Stabilized Spike Glycoproteins for COVID Research

We have produced stabilized Spike proteins for NIAID, now offered through BEI. Please check the details on the constructs and order them directly from (cat. NR-52724, NR-53937)


2021 Sep 07

Anti-IFNAR therapeutic antibody now available

The rhesus recombinant anti-Interferon alpha receptor (IFNAR) 1 'Anti-IFNAR [Ani]' is now available for distribution. This antibody binds to the receptor blocking the activity of type I interferons.


2021 Feb 15

How to Cite Our Reagents Using RRIDs

We are now using Research Resource Identifiers (RRIDs) on our entire catalog to facilitate proper antibody identification. The idea behind the use of resource identifiers is simple: citation of our antibodies (using unique RRIDs) will automatically associate specific reagents with your publication.

Contribute to the Resource

Help Us By:

Sharing Your Data: Our community-based reactivity database is built by users like you. Share your results!

Requesting a Reagent: We develop NHP-specific antibodies based on investigator-initiated requests, including: recombinant proteins for cell depletion, receptor activation, cytokine neutralization, co-stimulatory blockade, immunosuppression.

Licensing Our Reagents: Interested in using our antibodies on your assays? Reach us!

Sharing Your Publication: If you’ve recently published a study using an NHPRR reagent, add it to the publication database.